Skip to content
HowShorted

Biolase, Inc. short interest in 2020

In 2020, Biolase, Inc.'s disclosed short interest ran from 1.62% of shares outstanding on 15 Jan 2020 to 2.06% on 15 Dec 2020, a change of +0.44 percentage points. The year's high was 2.38% on 15 Apr 2020 and its low 0.30% on 15 Oct 2020, averaging 1.14% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.37 days on 31 Mar 2020. Full history: Biolase, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023

Aggregate net short position time series for Biolase, Inc. in 2020

2020 in figures

Start of year
1.62% (15 Jan 2020)
End of year
2.06% (15 Dec 2020)
Change
+0.44 pp
High
2.38% (15 Apr 2020)
Low
0.30% (15 Oct 2020)
Average
1.14%
Highest days to cover
4.37 (31 Mar 2020)
SEC filings marked
9

Every report in 2020

Biolase, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20201.62%3.49
31 Jan 20201.07%1.63
14 Feb 20200.99%1.62
28 Feb 20201.01%2.99
13 Mar 20200.95%2.61
31 Mar 20201.16%4.37results (8-K), 10-K filed
15 Apr 20202.38%1.00
30 Apr 20201.05%1.00
15 May 20201.20%1.00results (8-K), 10-Q filed
29 May 20201.02%1.00
30 Jun 20202.26%1.00
31 Jul 20201.95%1.00
14 Aug 20200.92%1.00results (8-K), 10-Q filed
31 Aug 20200.56%1.00
15 Sep 20200.56%1.00
30 Sep 20200.36%1.00
15 Oct 20200.30%1.00results (8-K)
30 Oct 20200.54%1.00
13 Nov 20200.98%1.00results (8-K), 10-Q filed
30 Nov 20201.04%1.00
15 Dec 20202.06%1.00

See also: Biolase, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.